A Conserved <scp> FABP5 <sup>high</sup> </scp> Macrophage Subset Promotes Fibrosis and Carcinogenesis in Advanced Liver Disease
Our findings provide insights into the evolution from chronic liver disease to liver cancer. These insights will contribute to the development of novel cell subset-based therapeutics based on immunotherapy and targeted therapy.
Authors
- E Weigao
- Daiyuan Liu
- Guoji Guo (ORCID: https://orcid.org/0000-0002-1716-4621)
- Qiang Sun (ORCID: https://orcid.org/0000-0002-6621-7064)
- Xiaoping Han (ORCID: https://orcid.org/0000-0003-3201-7635)
- Yuan Ding (ORCID: https://orcid.org/0000-0002-3840-9886)
- Bijun Cui
- Dongkai Zhou (ORCID: https://orcid.org/0000-0003-0705-9796)
- Chengxuan Yu (ORCID: https://orcid.org/0009-0005-8518-1326)
- Yutian Ji
- Weilin Wang (ORCID: https://orcid.org/0000-0001-9432-2649)
- Jingjing Wang (ORCID: https://orcid.org/0000-0002-8265-2752)
- Lifeng Ma
- Wenhao Ge
- Wei Zhu (ORCID: https://orcid.org/0000-0001-8923-3713)
- Jiarong Zhou (ORCID: https://orcid.org/0000-0003-1646-5374)
- Shujing Lai
- Yingsheng Wu
- Ye Song (ORCID: https://orcid.org/0009-0004-5957-7231)
- Yü Huang (ORCID: https://orcid.org/0000-0002-1277-6784)
- Yang Kong
Institutions
- Shanghai Jiao Tong University (CN)
- Zhejiang Cancer Hospital (CN)
- Zhejiang Lab (CN)
- Blood Center of Zhejiang Province (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Hangzhou Cancer Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Liver International
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1111/liv.70262
- Citations
- 2
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- National Natural Science Foundation of China